ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Medicamen Organics Limited received Rs. 12.29 Crore in consideration for a preferential allotment of equity shares and warrants. The auditor certified compliance with SEBI ICDR Regulations.
Medicamen Organics allotted equity shares and warrants worth ₹13.65 Crore on a preferential basis. This capital infusion strengthens the company's equity base and supports future growth.
Medicamen Organics reported 15.41% unutilized IPO proceeds, totaling ₹162.44 Lakhs. Shareholders approved reallocating these funds from international product registration to meeting working capital requirements.
Medicamen Organics Limited is undertaking a ₹13.65 Crore preferential issue of equity shares and warrants. The capital raise includes a loan conversion by a promoter.